Disease Areas
Diabetes
Obesity
Cardiovascular Disease (CVD)
Chronic Kidney Disease (CKD)
Metabolic Dysfunction-Associated Steatohepatitis (MASH)
Neurodegenerative Diseases
Haemophilia
Sickle Cell Disease
Primary Hyperoxaluria
Growth Hormone Disorders
Hormone Replacement Therapy
Congresses
Scientific Publications
IME
Search Science Hub
Register
Login
My Account
Welcome to Novo Nordisk Science Hub
Are you a healthcare professional?
No
Yes
Congresses
ASN 2025
Going with the FLOW: Semaglutide Reduces the Risk of Renal Complications in Early Diabetic Kidney Disease (DKD)
ASN 2025
ASN 2025
6 - 9 November 2025
Going with the FLOW: Semaglutide and the Risk of Kidney Complications in Early Diabetic Kidney Disease – A Large Registry Study
Authors
:
Genya Aharon-Hananel
1,2
; Johannes F. Mann
3
; Alona Aharonovich
4
; Efrat Leopold
5
; Gil Chernin
2,6
Affiliations
View Details
Hide Details
{{ getPageNum(PDFPage) }}
Share
Copy link
{{pageUrl}}
Keywords
Chronic Kidney Disease
Diabetes
Congress poster
GLP-1 RA
Semaglutide
RWE